Skip to content
type1.science

Medtronic Guardian 4

Medtronic

The factory-calibrated, no-fingerstick sensor that drives Medtronic's MiniMed 780G automated insulin delivery system. Reliable and well-integrated, but tied to Medtronic hardware, with a bulkier separate-transmitter design and a higher MARD (~10.8%) than Dexcom/Libre — and now being gradually superseded by the smaller, disposable Simplera Sync.

Available nowRegulator-approvedcgm

The scorecard

Accuracy70

Overall MARD of 10.8% in its pivotal trial — accurate enough to dose from without fingersticks, but a step behind the ~8% of Dexcom G7 and the latest FreeStyle Libre sensors.[1]

Low lag62

Reads interstitial fluid, so the same ~10–15 min physiological lag of all current sensors applies; not a differentiator, and not closed by this sensor.[2]

Interoperability30

A closed Medtronic ecosystem — drives only the MiniMed 780G pump (plus a standalone Guardian phone app in some regions). No compatibility with other pumps, and unusable by any open-source/DIY loop.[5]

Sensor lifespan60

7-day wear per sensor — shorter than the 10–15 day sensors now common from Dexcom and Abbott.[3]

No calibration90

Factory-calibrated and non-adjunctive — no routine fingersticks in SmartGuard mode (a few confirmation fingersticks can still be requested).[3]

Alerts & prediction80

Configurable high/low alerts plus predictive alerts up to 1 hour ahead, and it feeds the 780G's SmartGuard auto-correction and low-glucose suspend.[5]

Form factor45

Bulkier two-part design — a round sensor base plus a separate reusable rechargeable transmitter and overtape; larger and more involved than the all-in-one Dexcom/Libre sensors, and bigger than its own Simplera Sync successor.[7]

Ketone sensing0

No ketone sensing — glucose only.

Access & cost55

Available across the US, UK, EU, Canada and Australia and widely reimbursed, but you must be on a Medtronic 780G pump; without coverage it's ~4 sensors/month, and the US copay program caps its support and excludes Medicare patients.[9]

Editor’s take

A dependable workhorse, not a leader. The Guardian 4 does the job it was built for — driving the MiniMed 780G with no fingersticks — but it lags the field on accuracy (MARD ~10.8% vs ~8%), wear (7 days), bulk, and openness (Medtronic only, no DIY). If you're committed to the 780G it's a solid sensor; if sensor choice is what matters most to you, a Dexcom- or Libre-based system is usually the stronger pick. Its own successor, the smaller disposable Simplera Sync, is the real direction of travel.

The full picture

The Medtronic Guardian 4 is the continuous glucose monitor (CGM) that powers Medtronic's flagship MiniMed 780G automated insulin delivery (AID) system. You wear a small round sensor on your body, clip a separate reusable transmitter onto it, and cover both with an adhesive overtape; the transmitter wirelessly sends a glucose reading every 5 minutes to your pump (and, in some regions, to a standalone Guardian phone app).1 Its headline upgrade over older Medtronic sensors is that it is factory-calibrated and non-adjunctive — meaning no routine fingersticks are needed to use it.2

Accuracy. In its pivotal trial the Guardian 4 had an overall MARD of 10.8% (mean absolute relative difference — lower is better).3 That's genuinely good — accurate enough to dose insulin from without fingersticks — but it is a clear step behind the roughly 8% MARD of today's Dexcom G7 and the latest FreeStyle Libre sensors. Honest framing: it's reliable, not class-leading.

Wear, warm-up & calibration. Each sensor lasts 7 days, with a 2-hour warm-up after insertion.4 It needs no routine fingerstick calibration in SmartGuard mode, though fingersticks are still required in manual mode, to enter SmartGuard, and any time your symptoms don't match the readings.2 The transmitter is rechargeable and reusable: every 7 days you detach it from the old sensor, recharge it, and snap it onto a new one.4

Alerts & prediction. Beyond customizable high/low alerts, it gives predictive alerts up to an hour ahead of a high or low, and — most importantly — it feeds the 780G's SmartGuard algorithm, which auto-adjusts basal insulin, delivers automatic correction boluses every 5 minutes, and suspends insulin to defend against lows.1

What it works with. This is the Guardian 4's biggest limitation: it is a closed Medtronic ecosystem. It drives only the MiniMed 780G pump (plus a standalone Guardian app in some markets) and is not compatible with any other pump or with open-source/DIY loops such as Loop or AndroidAPS.1 If interoperability matters to you, this is the trade-off you accept for Medtronic's integrated system.

Ketones. None — like all current mainstream CGMs it senses glucose only and cannot warn you about the ketones that precede diabetic ketoacidosis (DKA).

Who it's for. People with diabetes ages 7 and older who use the MiniMed 780G.2

Access & cost. It's available across the US, UK, EU, Canada and Australia and is widely reimbursed — but only as part of a Medtronic 780G setup. You'll use roughly 4 sensors a month; in the US, Medtronic's pharmacy copay program caps the sensor support it offers and excludes Medicare and other government plans.5

What's coming. The Guardian 4 is being progressively superseded by Medtronic's Simplera Sync — a smaller, disposable, all-in-one sensor (no separate transmitter) that was FDA-approved in April 2025 and began a limited US launch in fall 2025.6 The 780G now supports both sensors, so the Guardian 4 remains available and supported during the transition while new users increasingly move to Simplera Sync.7

References

  1. Medtronic Diabetes Australia. Guardian 4 Sensor. Sensor glucose every 5 minutes; predictive alerts up to 1 hour ahead; ages 7+; standalone Guardian app. https://www.medtronic-diabetes.com.au/products/g4system ↩ ↩2 ↩3

  2. Medtronic. FDA Approves Medtronic MiniMed 780G System (2023). US approval 21 Apr 2023, ages 7+, no fingersticks while in SmartGuard. https://news.medtronic.com/2023-04-21-FDA-Approves-Medtronic-MiniMed-TM-780G-System-Worlds-First-Insulin-Pump-with-Meal-Detection-Technology-Featuring-5-Minute-Auto-Corrections ↩ ↩2 ↩3

  3. Cordero TL, et al. Glycemic Outcomes During Early Use of the MiniMed 780G Advanced Hybrid Closed-Loop System with Guardian 4 Sensor. Diabetes Technology & Therapeutics (2023). Reports the Guardian 4 pivotal-trial accuracy as MARD 10.8% ± 9.3%. PMID 37252734. https://doi.org/10.1089/dia.2023.0123 ↩

  4. Medtronic / MiniMed. Guardian 4 Sensor — Sensor and Transmitter Support. 2-hour warm-up; calibration-free; separate rechargeable transmitter. https://www.minimed.com/en-us/support/product-support/sensors/guardian-4/ ↩ ↩2

  5. Medtronic / MiniMed. CGM Pharmacy Copay Program. Capped sensor copay support; excludes Medicare and government-funded plans. https://www.minimed.com/en-us/financial-support-programs/cgm-pharmacy-copay/ ↩

  6. Medtronic. New Simplera Sync sensor for the MiniMed 780G System now FDA approved (2025). Disposable all-in-one sensor, smaller/lighter than the current sensor; FDA approval 18 Apr 2025; US limited launch fall 2025. https://news.medtronic.com/2025-04-18-New-Simplera-Sync-TM-sensor-for-the-MiniMed-TM-780G-System-now-FDA-approved ↩

  7. Simplera Sync sensor for MiniMed 780G now FDA approved. Med-Tech Insights (2025). Independent confirmation of approval, disposable design, and fall-2025 US limited launch. https://med-techinsights.com/2025/04/29/simplera-sync-sensor-for-minimed-780g-now-fda-approved/ ↩

What's next for this

  • →Being progressively superseded on the 780G by the smaller, disposable Simplera Sync sensor (FDA-approved Apr 2025); the 780G now supports both, and Guardian 4 remains available and supported during the transition. · US limited launch of Simplera Sync from fall 2025

Sources

  1. [1]Glycemic Outcomes During Early Use of the MiniMed 780G Advanced Hybrid Closed-Loop System with Guardian 4 Sensor · peer-reviewed · 2023-06-16 — Cordero TL, et al. Reports the Guardian 4 sensor's pivotal-trial accuracy as MARD 10.8% ± 9.3% (18,423 paired points); non-adjunctive, calibration-free; CE mark May 2021. PMID 37252734 / PMC10460682. Retrieved via PubMed/PMC.
  2. [2]Glycemic Outcomes During Early Use of the MiniMed 780G Advanced Hybrid Closed-Loop System with Guardian 4 Sensor (real-world use) · peer-reviewed · 2023-06-16 — Same study: real-world MM780G+G4S users (n>36,000) spent >90% of time in closed loop with ~0.8–1.0 fingersticks/day and ~0.1 closed-loop exits/day; CAS A1C 6.8% (adults) and 7.2% (ages 7–17). NCT03959423.
  3. [3]FDA Approves Medtronic MiniMed 780G System — World's First Insulin Pump with Meal Detection Technology Featuring 5-Minute Auto Corrections · manufacturer · 2023-04-21 — US FDA approval (21 Apr 2023) of the 780G with Guardian 4 sensor; ages 7+; no fingersticks while in SmartGuard (fingersticks required in manual mode and to enter SmartGuard); 5-minute auto-corrections.
  4. [4]Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen · manufacturer · 2021-05-26 — CE mark for the Guardian 4 sensor (26 May 2021); requires no fingersticks for calibration or treatment decisions; works with the 780G and a standalone Guardian app.
  5. [5]Guardian 4 Sensor — Medtronic Diabetes Australia · manufacturer — Sensor glucose readings every 5 minutes; predictive alerts up to 1 hour ahead of a high or low; ages 7+; works with a standalone Guardian smartphone app as well as the 780G.
  6. [6]Guardian 4 Sensor — Sensor and Transmitter Support · manufacturer — Official support page: 2-hour warm-up period; calibration-free; separate rechargeable transmitter that you detach, recharge and re-attach to each new sensor.
  7. [7]New Simplera Sync sensor for the MiniMed 780G System now FDA approved · manufacturer · 2025-04-18 — FDA approval (18 Apr 2025) of Simplera Sync — Medtronic's first disposable, all-in-one CGM, described as smaller and lighter than the current (Guardian 4) sensor; the 780G now supports both; limited US launch fall 2025.
  8. [8]Simplera Sync sensor for MiniMed 780G now FDA approved · news · 2025-04-29 — Independent confirmation of the Simplera Sync FDA approval, its disposable all-in-one design, and fall-2025 US limited launch — the path that gradually supersedes the Guardian 4.
  9. [9]CGM Pharmacy Copay Program · manufacturer — US copay program caps Guardian 4 sensor support and explicitly excludes Medicare and other government-funded plans.